The "Corneal Edema - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.A comprehensive report has been released providing valuable insights into the diagnosis, ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...

Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.

The following is a summary of “Regional differences in triage decisions affect hospital mortality among frail COVID-19 patients in the COvid MEdicaTion study,” published in the February 2025 issue of ...

By Noah Litherland, University of Minnesota Extension First-calf heifers represent the present and the future of dairy farms, but they need to adapt to many physiological and behavioral changes at ...

The severity of skin reactions to the treatment of actinic keratosis with 5-fluorouracil cream 4% was associated with a higher lesion clearance rate.

Tarzi, in this interview with GRACE EDEMA, shares insights on why online learning offers more benefits than the traditional onsite campus system and the need to emphasise applied learning.

The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.